Skip to main content
Fig. 3 | Infectious Agents and Cancer

Fig. 3

From: Brassicasterol inhibits hepatitis B virus-associated hepatocellular carcinoma development via suppression of AKT signaling pathway

Fig. 3

Brassicasterol inhibits HBV + HCC xenografted tumor growth in mice. Nude BLAB/c mice bearing xenografted HepG2.215-derived tumors were either mock-treated or treated with sorafenib or brassicasterol for 15 days. A Tumor volumes were measured every 3 days for up to 15 days since the treatment. *, p < 0.05. B Tumor sizes and C tumor weights on the day of animal sacrifice (day 16) were shown. ns, not statistically significant; *, p < 0.05; **, p < 0.01. Scale bar: 1 cm. D Mice were weighed every 3 days for up to 15 days since the treatment

Back to article page

Infectious Agents and Cancer

ISSN: 1750-9378

Contact us